Opportunity ID: 310904

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DD-19-002
Funding Opportunity Title: The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 93.315 — Rare Disorders: Research, Surveillance, Health Promotion, and Education
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 07, 2018
Last Updated Date: Feb 04, 2019
Original Closing Date for Applications: Feb 13, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Feb 13, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 15, 2019
Estimated Total Program Funding: $16,250,000
Award Ceiling: $375,000
Award Floor: $0

Eligibility

Eligible Applicants: Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
County governments
Native American tribal governments (Federally recognized)
State governments
City or township governments
For profit organizations other than small businesses
Private institutions of higher education
Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: For an applicant to be considered they must be responsive to the information here.
Component A – Core-Current:

Applicants must document current funding under RFA DD-14-001 Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders.

Component B – Core-New:

Applicants must propose a study site that should be a specific geographic area with a population of at least 3 million people including a large minority population (e.g. African American, Asian, or Hispanic).

Component C – Enhanced-Dissemination:

Applicants must submit an application for Component A to apply for Component C.
To be funded for Component C, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

Component D – Enhanced-DCC:

Applicants must submit an application for Component A or B to apply for Component D.
To be funded for Component D, the applicant must also be funded for Component A or B.
Applicants should document that they have applied for Component A or B.

Component E – Enhanced-Abstractor:

Applicants must submit an application for Component A to apply for Component E.
To be funded for Component E, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter the review process.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this NOFO is to better understand the public health and clinical impacts of living with MD by conducting longitudinal, population-based surveillance and research of eligible MDs (DMD, BMD, DM, FSHD, LGMD, CMD, EDMD, OPMD, and Distal MD). The current cycle will focus on identifying eligible MD cases, conducting longitudinal follow-up and research, analyzing data, and publishing and disseminating the results. Current MD STARnet sites will collect data to estimate prevalence and survival and additional clinical data on existing MD cohorts. New MD STARnet sites will focus on identifying eligible MD cases and collecting data to estimate prevalence, survival and track key clinical indicators. Identification of cases through population-based surveillance will enable existing and new sites to conduct research on these populations. This information is expected to advance understanding of diagnosed prevalence, disease progression and survival; clinical care and interventions and their alignment with recommended care; disparities in access to care; the association of treatment with outcomes, and the impact of MD on the lives of affected individuals and their families.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Marcella Law
mah7@cdc.gov
Email:mah7@cdc.gov

Version History

Version Modification Description Updated Date
Amend NOFO to add Q&A. Feb 04, 2019
Feb 04, 2019

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DD-19-002
Funding Opportunity Title: The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 93.315 — Rare Disorders: Research, Surveillance, Health Promotion, and Education
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 07, 2018
Last Updated Date: Feb 04, 2019
Original Closing Date for Applications: Feb 13, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Feb 13, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 15, 2019
Estimated Total Program Funding: $16,250,000
Award Ceiling: $375,000
Award Floor: $0

Eligibility

Eligible Applicants: Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
County governments
Native American tribal governments (Federally recognized)
State governments
City or township governments
For profit organizations other than small businesses
Private institutions of higher education
Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: For an applicant to be considered they must be responsive to the information here.
Component A – Core-Current:

Applicants must document current funding under RFA DD-14-001 Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders.

Component B – Core-New:

Applicants must propose a study site that should be a specific geographic area with a population of at least 3 million people including a large minority population (e.g. African American, Asian, or Hispanic).

Component C – Enhanced-Dissemination:

Applicants must submit an application for Component A to apply for Component C.
To be funded for Component C, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

Component D – Enhanced-DCC:

Applicants must submit an application for Component A or B to apply for Component D.
To be funded for Component D, the applicant must also be funded for Component A or B.
Applicants should document that they have applied for Component A or B.

Component E – Enhanced-Abstractor:

Applicants must submit an application for Component A to apply for Component E.
To be funded for Component E, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter the review process.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this NOFO is to better understand the public health and clinical impacts of living with MD by conducting longitudinal, population-based surveillance and research of eligible MDs (DMD, BMD, DM, FSHD, LGMD, CMD, EDMD, OPMD, and Distal MD). The current cycle will focus on identifying eligible MD cases, conducting longitudinal follow-up and research, analyzing data, and publishing and disseminating the results. Current MD STARnet sites will collect data to estimate prevalence and survival and additional clinical data on existing MD cohorts. New MD STARnet sites will focus on identifying eligible MD cases and collecting data to estimate prevalence, survival and track key clinical indicators. Identification of cases through population-based surveillance will enable existing and new sites to conduct research on these populations. This information is expected to advance understanding of diagnosed prevalence, disease progression and survival; clinical care and interventions and their alignment with recommended care; disparities in access to care; the association of treatment with outcomes, and the impact of MD on the lives of affected individuals and their families.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Marcella Law
mah7@cdc.gov
Email:mah7@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DD-19-002
Funding Opportunity Title: The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 93.315 — Rare Disorders: Research, Surveillance, Health Promotion, and Education
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 04, 2019
Last Updated Date: Dec 07, 2018
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 13, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 15, 2019
Estimated Total Program Funding: $16,250,000
Award Ceiling: $375,000
Award Floor: $0

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Special district governments
Public and State controlled institutions of higher education
State governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Independent school districts
Small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: For an applicant to be considered they must be responsive to the information here.
Component A – Core-Current:

Applicants must document current funding under RFA DD-14-001 Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders.

Component B – Core-New:

Applicants must propose a study site that should be a specific geographic area with a population of at least 3 million people including a large minority population (e.g. African American, Asian, or Hispanic).

Component C – Enhanced-Dissemination:

Applicants must submit an application for Component A to apply for Component C.
To be funded for Component C, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

Component D – Enhanced-DCC:

Applicants must submit an application for Component A or B to apply for Component D.
To be funded for Component D, the applicant must also be funded for Component A or B.
Applicants should document that they have applied for Component A or B.

Component E – Enhanced-Abstractor:

Applicants must submit an application for Component A to apply for Component E.
To be funded for Component E, the applicant must also be funded for Component A.
Applicants should document that they have applied for Component A.

If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter the review process.

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this NOFO is to better understand the public health and clinical impacts of living with MD by conducting longitudinal, population-based surveillance and research of eligible MDs (DMD, BMD, DM, FSHD, LGMD, CMD, EDMD, OPMD, and Distal MD). The current cycle will focus on identifying eligible MD cases, conducting longitudinal follow-up and research, analyzing data, and publishing and disseminating the results. Current MD STARnet sites will collect data to estimate prevalence and survival and additional clinical data on existing MD cohorts. New MD STARnet sites will focus on identifying eligible MD cases and collecting data to estimate prevalence, survival and track key clinical indicators. Identification of cases through population-based surveillance will enable existing and new sites to conduct research on these populations. This information is expected to advance understanding of diagnosed prevalence, disease progression and survival; clinical care and interventions and their alignment with recommended care; disparities in access to care; the association of treatment with outcomes, and the impact of MD on the lives of affected individuals and their families.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Marcella Law
mah7@cdc.gov
Email:mah7@cdc.gov

Folder 310904 Full Announcement-FULL_ANNOUNCEMENT -> RFA-DD-19-002 AMEND.pdf

Folder 310904 Full Announcement-The Muscular Dystrophy Surveil -> RFA-DD-19-002 FINAL.pdf

Packages

Agency Contact Information: Marcella Law
mah7@cdc.gov
Email: mah7@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.315 RFA-DD-19-002 The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) PKG00246726 Dec 07, 2018 Feb 13, 2019 View

Package 1

Mandatory forms

310904 RR_SF424_2_0-2.0.pdf

310904 RR_Budget_1_4-1.4.pdf

310904 PHS398_ResearchPlan_4_0-4.0.pdf

310904 PHS398_CoverPageSupplement_4_0-4.0.pdf

310904 RR_OtherProjectInfo_1_4-1.4.pdf

310904 PerformanceSite_2_0-2.0.pdf

310904 RR_KeyPersonExpanded_2_0-2.0.pdf

Optional forms

310904 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-09T09:56:04-05:00

Share This Post, Choose Your Platform!

About the Author: